| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/07/2001 | WO2001064691A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064687A1 Anti-infective ecta?tm¿ |
| 09/07/2001 | WO2001064679A1 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 09/07/2001 | WO2001064678A2 Inhibitors of hepatitis c virus ns3 protease |
| 09/07/2001 | WO2001064675A1 Condensed thiazolamines and their use as neuropeptide y5 antagonists |
| 09/07/2001 | WO2001064673A1 Flavone derivatives, preparation method and use as medicines |
| 09/07/2001 | WO2001064660A1 Novel quinoline ligands and metal complexes for diagnosis and therapy |
| 09/07/2001 | WO2001064244A2 In ovo protection against infectious bronchitis |
| 09/07/2001 | WO2001064234A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | WO2001064225A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 09/07/2001 | WO2001064221A1 Low dose entecavir formulation and use |
| 09/07/2001 | WO2001064211A1 Specific therapeutic composition for treating aids |
| 09/07/2001 | WO2001064208A1 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064186A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 09/07/2001 | WO2001064183A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 09/07/2001 | WO2001064165A2 Il-8 receptor antagonists |
| 09/07/2001 | WO2001064034A1 Antimicrobial sanitizing lotion with skin protection properties |
| 09/07/2001 | WO2001064013A2 Methods and compositions for inhibition of membrane fusion-associated events including rsv transmission |
| 09/07/2001 | WO2001016163A3 Peptide mixture and vaccine against a chronic viral infection |
| 09/07/2001 | WO2001012804A3 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 09/07/2001 | WO2001010408A3 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2001007432A8 Aminopiperidine derivatives as antibacterials |
| 09/07/2001 | WO2001000197A3 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 09/07/2001 | WO2000076528A3 Pharmaceutical preparation containing proteins |
| 09/07/2001 | WO2000075107A3 Bradykinin receptor antagonists |
| 09/07/2001 | WO2000047227A9 Mycobacterium tuberculosis, immunization |
| 09/07/2001 | WO2000046389A9 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 09/07/2001 | CA2402054A1 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 09/07/2001 | CA2401804A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 09/07/2001 | CA2401660A1 Lipid metabolism enzymes |
| 09/07/2001 | CA2401659A1 Il-8 receptor antagonists |
| 09/07/2001 | CA2401652A1 High potency recombinant antibodies and method for producing them |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401550A1 Casein derived peptides and uses thereof in therapy |
| 09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | CA2401405A1 Medicament for viral diseases |
| 09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
| 09/07/2001 | CA2401151A1 Anti-infective ectatm |
| 09/07/2001 | CA2401145A1 In ovo protection against infectious bronchitis |
| 09/07/2001 | CA2400950A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 09/07/2001 | CA2396504A1 Inhibitors of hepatitis c virus ns3 protease |
| 09/07/2001 | CA2374585A1 Antimicrobial sanitizing lotion with skin protection properties |
| 09/07/2001 | CA2339676A1 Use of heteroaryl substituted n-(indole-2-carbonyl-) amides for treatment of infection |
| 09/06/2001 | WO2001064715A2 Memno peptides, a process for their preparation and their use |
| 09/06/2001 | US20010020018 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/06/2001 | US20010020010 Polypeptide |
| 09/06/2001 | US20010020005 Administering a gastrin inhibitor |
| 09/06/2001 | US20010019716 Ability to enter mammalian cells and to survive within macrophages; vaccines to prevent infection by Mycobacterium tuberculosis, diagnostic assays |
| 09/06/2001 | US20010019714 Hiv-specific cytotoxic t-cell responses |
| 09/06/2001 | CA2339051A1 Ketolide antibiotics |
| 09/05/2001 | EP1130088A1 Hybrid cell vaccines |
| 09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
| 09/05/2001 | EP1130027A1 Memno peptides, process for preparation and use thereof |
| 09/05/2001 | EP1130016A1 Thiocarbamic acid derivatives |
| 09/05/2001 | EP1129723A1 Combined vaccine against both hav and measle virus and method of producing it |
| 09/05/2001 | EP1129722A1 gM-negative EHV-mutants |
| 09/05/2001 | EP1129720A2 Stabilized granulocyte colony stimulating factor |
| 09/05/2001 | EP1129694A1 Use of components for modifying physico-chemical properties of the skin and/or the mucosal tissue as adhesion prevention/decreasing adhesion agents for microorganisms |
| 09/05/2001 | EP1129213A1 Bacillus strain and assay methods |
| 09/05/2001 | EP1129212A1 Screening process for antibacterial agents |
| 09/05/2001 | EP1129208A1 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 09/05/2001 | EP1129202A2 Chlamydia antigenes and corresponding dna fragments and uses thereof |
| 09/05/2001 | EP1129201A1 Lysozyme fusion proteins in infections |
| 09/05/2001 | EP1129197A1 CATFIIIA CANDIDA ALBICANS tfIIIA GENE (CatfIIIA) AND THE CODED CATFIIIA PROTEIN |
| 09/05/2001 | EP1129196A2 Virulence genes and proteins, and their use |
| 09/05/2001 | EP1129193A1 Chemokine beta-7 |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129177A1 Avipox vector coding an hiv antigen and a cytokine |
| 09/05/2001 | EP1129108A1 Caspases and apoptosis |
| 09/05/2001 | EP1129088A2 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
| 09/05/2001 | EP1129086A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 09/05/2001 | EP1129079A2 2,4-disubstituded triazine derivatives with anti hiv activity |
| 09/05/2001 | EP1129070A1 Neurotrophic diamide and carbamate agents |
| 09/05/2001 | EP1128843A2 Vaccine against papillomatous digital dermatitis (pdd) |
| 09/05/2001 | EP1128832A1 Compounds, compositions and methods for treating or preventing viral infections and associated diseases |
| 09/05/2001 | EP1128831A1 Pharmaceutical moxifloxacin preparation |
| 09/05/2001 | EP1128824A1 Ionic silver complex |
| 09/05/2001 | EP1128814A1 Aerosols comprising nanoparticle drugs |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP1128730A1 Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the n-hydroxyanilide-type |
| 09/05/2001 | EP1128723A1 Aromatic copolyester containing active ingredients |
| 09/05/2001 | EP0956029A4 Cyclic peptides having broad spectrum antimicrobial activity |
| 09/05/2001 | EP0807112B1 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
| 09/05/2001 | EP0637300B1 Antiproliferative quinazolines |
| 09/05/2001 | CN1311820A BASB027 protein and genes from i(Moraxella Catarrhalis), antigens, antibodies, and uses |
| 09/05/2001 | CN1311797A Process for producing immunolobulins for intravenous administration and other immunolobulin products |
| 09/05/2001 | CN1311796A Peptide antiangiogenic drugs |
| 09/05/2001 | CN1311795A Method for purification of i(Borrelia) lipoprotein OSPA |
| 09/05/2001 | CN1311794A Aerothricin analogs, their prepn. and use |
| 09/05/2001 | CN1311793A Antipicornaviral compounds, their prepn. and use |
| 09/05/2001 | CN1311790A Novel C-2 5/O-and S/N formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta lactamase inhibitors |
| 09/05/2001 | CN1311787A Oxazolidinone derivatives, process for their prepn. and pharmaceutical compositions contg. same |
| 09/05/2001 | CN1311690A Porcine circovirus and parvovirus vaccine |
| 09/05/2001 | CN1311689A Viral chimeras comprised of CAEV and HIV-1 genetic elements |
| 09/05/2001 | CN1311685A Composite biocidal particles |
| 09/05/2001 | CN1311671A Peptidyl-prolyl i-(cis)-trans isomerase inhitors and uses thereof |
| 09/05/2001 | CN1311666A Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 09/05/2001 | CN1311660A Anti-germ attachment composition |